Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors.
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3823-7. doi: 10.1016/j.bmcl.2011.04.016. Epub 2011 Apr 16.
Bioorg Med Chem Lett. 2011.
PMID: 21565498
Structure-based lead identification of ATP-competitive MK2 inhibitors.
Barf T, Kaptein A, de Wilde S, van der Heijden R, van Someren R, Demont D, Schultz-Fademrecht C, Versteegh J, van Zeeland M, Seegers N, Kazemier B, van de Kar B, van Hoek M, de Roos J, Klop H, Smeets R, Hofstra C, Hornberg J, Oubrie A.
Barf T, et al. Among authors: van de kar b.
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3818-22. doi: 10.1016/j.bmcl.2011.04.018. Epub 2011 Apr 16.
Bioorg Med Chem Lett. 2011.
PMID: 21565500
Item in Clipboard
Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series.
Oubrie A, Kaptein A, de Zwart E, Hoogenboom N, Goorden R, van de Kar B, van Hoek M, de Kimpe V, van der Heijden R, Borsboom J, Kazemier B, de Roos J, Scheffers M, Lommerse J, Schultz-Fademrecht C, Barf T.
Oubrie A, et al. Among authors: van de kar b.
Bioorg Med Chem Lett. 2012 Jan 1;22(1):613-8. doi: 10.1016/j.bmcl.2011.10.071. Epub 2011 Nov 3.
Bioorg Med Chem Lett. 2012.
PMID: 22119462
Item in Clipboard
Discovery of quinoline-based irreversible BTK inhibitors.
de Bruin G, Demont D, de Zwart E, Verkaik S, Hoogenboom N, van de Kar B, van Lith B, Emmelot-van Hoek M, Gulrajani M, Covey T, Kaptein A, Barf T.
de Bruin G, et al. Among authors: van de kar b.
Bioorg Med Chem Lett. 2020 Jul 15;30(14):127261. doi: 10.1016/j.bmcl.2020.127261. Epub 2020 May 13.
Bioorg Med Chem Lett. 2020.
PMID: 32527559
Item in Clipboard
Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitors.
Hoogenboom N, Demont D, de Zwart E, Verkaik S, Emmelot M, van de Kar B, Kaptein A, Barf T.
Hoogenboom N, et al. Among authors: van de kar b.
Bioorg Med Chem Lett. 2021 Nov 15;52:128406. doi: 10.1016/j.bmcl.2021.128406. Epub 2021 Oct 5.
Bioorg Med Chem Lett. 2021.
PMID: 34624491
Item in Clipboard
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.
Barf T, Covey T, Izumi R, van de Kar B, Gulrajani M, van Lith B, van Hoek M, de Zwart E, Mittag D, Demont D, Verkaik S, Krantz F, Pearson PG, Ulrich R, Kaptein A.
Barf T, et al. Among authors: van de kar b.
J Pharmacol Exp Ther. 2017 Nov;363(2):240-252. doi: 10.1124/jpet.117.242909. Epub 2017 Sep 7.
J Pharmacol Exp Ther. 2017.
PMID: 28882879
Item in Clipboard
Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study.
Liu N, Hoogendoorn S, van de Kar B, Kaptein A, Barf T, Driessen C, Filippov DV, van der Marel GA, van der Stelt M, Overkleeft HS.
Liu N, et al. Among authors: van de kar b.
Org Biomol Chem. 2015 May 14;13(18):5147-57. doi: 10.1039/c5ob00474h.
Org Biomol Chem. 2015.
PMID: 25849561
Item in Clipboard
[Resident psychiatrists in Amsterdam recognize the value of personal therapy].
Piras GM, Van de Kar BW, Oostindiër A, Schwarz RV.
Piras GM, et al. Among authors: van de kar bw.
Tijdschr Psychiatr. 2006;48(5):361-72.
Tijdschr Psychiatr. 2006.
PMID: 16956026
Dutch.
Item in Clipboard
Cite
Cite